v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   132,992      
Beginning balance at Dec. 31, 2023 $ 979,488 $ 3 $ 1,815,245 $ (1,008) $ (834,752)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of vested stock options (in shares)   71      
Exercise of vested stock options 111   111    
Vesting of restricted stock units (in shares)   1,532      
Shares issued under bonus program (in shares)   1,889      
Shares issued under bonus program 26,849   26,849    
Stock-based compensation 28,298   28,298    
Net loss (43,427)       (43,427)
Other comprehensive (loss) income 487     487  
Ending balance (in shares) at Mar. 31, 2024   136,484      
Ending balance at Mar. 31, 2024 $ 991,806 $ 3 1,870,503 (521) (878,179)
Beginning balance (in shares) at Dec. 31, 2024 142,100 142,086      
Beginning balance at Dec. 31, 2024 $ 965,250 $ 3 1,958,157 (100) (992,810)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of vested stock options (in shares) 168 168      
Exercise of vested stock options $ 408   408    
Vesting of restricted stock units (in shares)   1,481      
Shares issued under bonus program (in shares)   951      
Shares issued under bonus program 6,898   6,898    
Stock-based compensation 23,645   23,645    
Net loss (39,148)       (39,148)
Other comprehensive (loss) income $ (30)     (30)  
Ending balance (in shares) at Mar. 31, 2025 144,700 144,686      
Ending balance at Mar. 31, 2025 $ 957,023 $ 3 $ 1,989,108 $ (130) $ (1,031,958)